Vimarsana
Biggest News Aggregation in the World

Nilofer Azad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nilofer Azad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nilofer Azad Today - Breaking & Trending Today

Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December - Vimarsana News

Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December

Published: November 30, 2021

/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesFox Chase Cancer CenterNew York Presbyterian Hospital Columbia University Medical CenterSan AntonioEdna KaplanNilofer AzadLillianl SiuMatthew InghamSyed MahmoodLos AngelesAnthonyj OlszanskiPhilippe BedardMichael MillerJacob ThomasBristol Myers SquibbAnthony El KhoueiryDiana HannaIanb WaltersMerck Sharpe DohmeLewish BenderGiles WhalenOttawa Hospital Research InstituteNational Cancer InstituteBristol Myers Squibb Company
Intensity Therapeutics' Data on Lead Asset, INT230-6, Accepted for Presentation at Two Major Scientific Clinical Oncology Conferences in November - Vimarsana News

Intensity Therapeutics' Data on Lead Asset, INT230-6, Accepted for Presentation at Two Major Scientific Clinical Oncology Conferences in November

Published: November 3, 2021

/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...

Source: prnewswire.com
Related Topics:
United StatesEdna KaplanNilofer AzadLilianl SiuMatthew InghamSyed MahmoodChristianf MeyerAnthonyj OlszanskiMatthewa InghamGilesf WhalenMichael MillerJacob ThomasBristol Myers SquibbAnthony El KhoueiryDiana HannaIanb WaltersMerck Sharpe DohmeLewish BenderAlbirunir RazakDevelopment AgreementOntario Institute Of Cancer ResearchOttawa Hospital Research InstituteNational Cancer InstituteSociety For Immunotherapy Of CancerBristol Myers Squibb Company